Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2022.
Auteur principal: | Shaikat, Mahdi Mubin |
---|---|
Autres auteurs: | Bin Naser, Dr. Iftekhar |
Format: | Thèse |
Langue: | English |
Publié: |
Brac University
2023
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/18984 |
Documents similaires
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
par: Maria, Amatul
Publié: (2020) -
A review on CRISPR-Cas system based applications in Oncology
par: Sadia, Mir
Publié: (2022) -
A review on CRISPR Technology as an Antiviral Tool
par: Srishti, Sanjida Ahmed
Publié: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
par: Ullah, Mohammad
Publié: (2023) -
A review paper on Nanotechnology based strategies in the treatment of cancer
par: Rahman, Samia
Publié: (2022)